activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2147393	CHEMBL922178	Activity of human Snk kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL5938	Homo sapiens	Activity	%	110.0
	2147393	CHEMBL922178	Activity of human Snk kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	110.0	CHEMBL5938	Homo sapiens	Activity	%	110.0
Active	2197837	CHEMBL995301	Inhibition of AX-7503 binding to recombinant Plk2 at 1 uM by Western blot	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496		Activity			CHEMBL5938	Homo sapiens	Activity		
	2486523	CHEMBL991583	Inhibition of human Plk2	B	Cc1cccc(-c2noc3cnc(N[C@@H](C)c4ccccc4)cc23)c1		CHEMBL489992	=	IC50	nM	1449.0	CHEMBL5938	Homo sapiens	IC50	uM	1.449
	2486525	CHEMBL991583	Inhibition of human Plk2	B	C[C@H](Nc1cc2c(-c3cc(Cl)cc(CCC(N)=O)c3)noc2cn1)c1ccccc1		CHEMBL491021	=	IC50	nM	172.0	CHEMBL5938	Homo sapiens	IC50	uM	0.172
	2486526	CHEMBL991583	Inhibition of human Plk2	B	C[C@H](Nc1cc2c(-c3ccc4c(c3)OCO4)noc2cn1)c1ccccc1		CHEMBL522618	=	IC50	nM	4.0	CHEMBL5938	Homo sapiens	IC50	uM	0.004
	2511604	CHEMBL973458	Inhibition of PLK2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	197.0	CHEMBL5938	Homo sapiens	IC50	uM	0.197
	2511619	CHEMBL973458	Inhibition of PLK2	B	COc1ccc(NC(=S)N/N=C2\C(=O)Nc3ccccc32)cc1		CHEMBL504574	>	IC50	nM	50000.0	CHEMBL5938	Homo sapiens	IC50	uM	50.0
	2511976	CHEMBL973493	Inhibition of PLK2 at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	12.0	CHEMBL5938	Homo sapiens	INH	%	12.0
	2721528	CHEMBL1059126	Inhibition of PLK2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	>	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	2721530	CHEMBL1059128	Inhibition of PLK2	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	=	IC50	nM	21.0	CHEMBL5938	Homo sapiens	IC50	nM	21.0
	3052485	CHEMBL1072523	Residual activity of SNK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	89.0	CHEMBL5938	Homo sapiens	Residual activity	%	89.0
	3052737	CHEMBL1043816	Residual activity of SNK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	94.0	CHEMBL5938	Homo sapiens	Residual activity	%	94.0
	3054046	CHEMBL1071376	Residual activity of SNK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	99.0	CHEMBL5938	Homo sapiens	Residual activity	%	99.0
	3055333	CHEMBL1072523	Residual activity of SNK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	89.0	CHEMBL5938	Homo sapiens	Residual activity	%	89.0
	3055585	CHEMBL1043816	Residual activity of SNK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL5938	Homo sapiens	Residual activity	%	86.0
	3056890	CHEMBL1071376	Residual activity of SNK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	108.0	CHEMBL5938	Homo sapiens	Residual activity	%	108.0
	3057142	CHEMBL1072523	Residual activity of SNK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	108.0	CHEMBL5938	Homo sapiens	Residual activity	%	108.0
	3058462	CHEMBL1043816	Residual activity of SNK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	86.0	CHEMBL5938	Homo sapiens	Residual activity	%	86.0
	3059746	CHEMBL1071376	Residual activity of SNK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	120.0	CHEMBL5938	Homo sapiens	Residual activity	%	120.0
	3127412	CHEMBL1064450	Inhibition of PLK2 by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3127446	CHEMBL1064450	Inhibition of PLK2 by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3214029	CHEMBL1103224	Inhibition of PLK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL5938	Homo sapiens	INH	%	3.0
	3224923	CHEMBL1101001	Inhibition of PLK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3226302	CHEMBL1101001	Inhibition of PLK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3291432	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	=	IC50	nM	238.0	CHEMBL5938	Homo sapiens	IC50	uM	0.238
	3291747	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094477	=	IC50	nM	2.0	CHEMBL5938	Homo sapiens	IC50	uM	0.002
	3291749	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL559845	=	IC50	nM	9.0	CHEMBL5938	Homo sapiens	IC50	uM	0.009
	3291756	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CNc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095457	=	IC50	nM	12.0	CHEMBL5938	Homo sapiens	IC50	uM	0.012
	3291757	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3N)ncc1CC2		CHEMBL1097022	=	IC50	nM	12.0	CHEMBL5938	Homo sapiens	IC50	uM	0.012
	3291759	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CSc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094478	=	IC50	nM	14.0	CHEMBL5938	Homo sapiens	IC50	uM	0.014
	3291765	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3F)ncc1CC2		CHEMBL1095771	=	IC50	nM	27.0	CHEMBL5938	Homo sapiens	IC50	uM	0.027
	3291772	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095717	=	IC50	nM	82.0	CHEMBL5938	Homo sapiens	IC50	uM	0.082
	3292699	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(C)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095772	=	IC50	nM	509.0	CHEMBL5938	Homo sapiens	IC50	uM	0.509
	3292724	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)Nc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1097373	=	IC50	nM	2104.0	CHEMBL5938	Homo sapiens	IC50	uM	2.104
	3292730	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Oc3ccccc3)ncc1CC2		CHEMBL1096095	=	IC50	nM	2666.0	CHEMBL5938	Homo sapiens	IC50	uM	2.666
	3292792	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)cccc1N1CCN(C)CC1		CHEMBL1097374	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3292796	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1096028	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3292800	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1095716	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
Not Determined	3292806	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COC(=O)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094484		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292808	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(N)=O)ncc1CC2		CHEMBL1094815		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292810	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3S(N)(=O)=O)ncc1CC2		CHEMBL1094816		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292812	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3-c3ccccc3)ncc1CC2		CHEMBL1094817		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292814	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Cc3ccccc3)ncc1CC2		CHEMBL1094488		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292816	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Nc3ccccc3)ncc1CC2		CHEMBL1094820		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292818	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(=O)c3ccccc3)ncc1CC2		CHEMBL1094821		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3292820	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3Sc3ccccc3)ncc1CC2		CHEMBL1094822		IC50			CHEMBL5938	Homo sapiens	IC50		
	3292824	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3C(F)(F)F)ncc1CC2		CHEMBL1097071	=	IC50	nM	109.0	CHEMBL5938	Homo sapiens	IC50	uM	0.109
	3292827	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CC(=O)c1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1099104	=	IC50	nM	261.0	CHEMBL5938	Homo sapiens	IC50	uM	0.261
	3292830	CHEMBL1109142	Inhibition of Plk2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccccc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094135	=	IC50	nM	24.0	CHEMBL5938	Homo sapiens	IC50	uM	0.024
	3332107	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3333522	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3334927	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3336347	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3341889	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	3343336	CHEMBL1166818	Inhibition of PLK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	82.0	CHEMBL5938	Homo sapiens	INH	%	82.0
	3358761	CHEMBL1175227	Inhibition of PLK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	100.0	CHEMBL5938	Homo sapiens	INH	%	100.0
	3359203	CHEMBL1175227	Inhibition of PLK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL5938	Homo sapiens	INH	%	100.0
	3370120	CHEMBL1176628	Inhibition of PLK2 at 10 uM	B	COc1ccc(NC(=O)Nc2ccc3c(c2)NC(=O)/C3=C\c2[nH]cc(C(=O)O)c2C)cc1		CHEMBL1173411	=	Inhibition	%	0.0	CHEMBL5938	Homo sapiens	INH	%	0.0
	3443487	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	5.0	CHEMBL5938	Homo sapiens	INH	%	5.0
	3443704	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	2.0	CHEMBL5938	Homo sapiens	INH	%	2.0
	3444859	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	9.0	CHEMBL5938	Homo sapiens	INH	%	9.0
	3445261	CHEMBL1244933	Binding affinity to PLK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	330.0	CHEMBL5938	Homo sapiens	Kd	nM	330.0
	3445483	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	3.0	CHEMBL5938	Homo sapiens	INH	%	3.0
	3445700	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	32.0	CHEMBL5938	Homo sapiens	INH	%	32.0
	3445895	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	7.0	CHEMBL5938	Homo sapiens	INH	%	7.0
	3446085	CHEMBL1244253	Inhibition of PLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	5.0	CHEMBL5938	Homo sapiens	INH	%	5.0
	3448580	CHEMBL1244933	Binding affinity to PLK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	uM	10.0
	3449488	CHEMBL1244933	Binding affinity to PLK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	2000.0	CHEMBL5938	Homo sapiens	Kd	nM	2000.0
	3449489	CHEMBL1244933	Binding affinity to PLK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4700.0	CHEMBL5938	Homo sapiens	Kd	nM	4700.0
	3449811	CHEMBL1244933	Binding affinity to PLK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	uM	10.0
	3450206	CHEMBL1244933	Binding affinity to PLK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	uM	10.0
	3450853	CHEMBL1244933	Binding affinity to PLK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	uM	10.0
	3463320	CHEMBL1252622	Inhibition of PLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	6.0	CHEMBL5938	Homo sapiens	INH	%	6.0
	3463864	CHEMBL1252622	Inhibition of PLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	24.0	CHEMBL5938	Homo sapiens	INH	%	24.0
	3464083	CHEMBL1252622	Inhibition of PLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	38.0	CHEMBL5938	Homo sapiens	INH	%	38.0
	3528130	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C(=O)N5CCNCC5)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1269488	=	IC50	nM	190.0	CHEMBL5938	Homo sapiens	IC50	uM	0.19
	3528132	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3OC(F)(F)F)ncc1CC2		CHEMBL1272089	=	IC50	nM	206.0	CHEMBL5938	Homo sapiens	IC50	uM	0.206
	3528135	CHEMBL1272695	Inhibition of PLK2	B	C=Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1793896	=	IC50	nM	335.0	CHEMBL5938	Homo sapiens	IC50	uM	0.335
	3528137	CHEMBL1272695	Inhibition of PLK2	B	CN1CCCC1CCNc1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL1271535	=	IC50	nM	429.0	CHEMBL5938	Homo sapiens	IC50	uM	0.429
	3528142	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(NC4CCNC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1271591	=	IC50	nM	762.0	CHEMBL5938	Homo sapiens	IC50	uM	0.762
	3528143	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C(=O)OC(C)(C)C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1269487	=	IC50	nM	768.0	CHEMBL5938	Homo sapiens	IC50	uM	0.768
	3528155	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1269042	=	IC50	nM	1282.0	CHEMBL5938	Homo sapiens	IC50	uM	1.282
	3528169	CHEMBL1272695	Inhibition of PLK2	B	CCN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1271590	=	IC50	nM	3387.0	CHEMBL5938	Homo sapiens	IC50	uM	3.387
	3528170	CHEMBL1272695	Inhibition of PLK2	B	CN1CCC(Nc2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1272300	=	IC50	nM	3415.0	CHEMBL5938	Homo sapiens	IC50	uM	3.415
	3528172	CHEMBL1272695	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1272140	=	IC50	nM	3519.0	CHEMBL5938	Homo sapiens	IC50	uM	3.519
	3528196	CHEMBL1272695	Inhibition of PLK2	B	CN1CCCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1272195	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528199	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCC(N5CCCC5)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1272250	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528202	CHEMBL1272695	Inhibition of PLK2	B	CN1C(C)(C)CC(Nc2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1(C)C		CHEMBL1271482	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528205	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCNCC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1271644	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528207	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CC[N+](C)([O-])CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1271645	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528209	CHEMBL1272695	Inhibition of PLK2	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc([N+]4([O-])CC[N+](C)([O-])CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1271694	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528215	CHEMBL1272695	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3[nH]nc(C(N)=O)c3CC4)c2)CC1		CHEMBL1793891	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528219	CHEMBL1272695	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCF)CC4)c2)CC1		CHEMBL1793892	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528222	CHEMBL1272695	Inhibition of PLK2	B	CCn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1793893	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528225	CHEMBL1272695	Inhibition of PLK2	B	COCCn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1793894	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	3528228	CHEMBL1272695	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCCl)CC4)c2)CC1		CHEMBL1793895	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
Not Determined	3528234	CHEMBL1272695	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C(c3ccccc3)(c3ccccc3)c3ccccc3)CC4)c2)CC1		CHEMBL1269489		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	3528236	CHEMBL1272695	Inhibition of PLK2	B	COc1ccc(Cn2nc(C(N)=O)c3c2-c2nc(Nc4cc(N5CCNCC5)ccc4OC(F)(F)F)ncc2CC3)cc1		CHEMBL1269490		IC50			CHEMBL5938	Homo sapiens	IC50		
	3603119	CHEMBL1291216	Inhibition of PLK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scnc1-c1cscn1		CHEMBL1288160	=	Inihibition	%	24.0	CHEMBL5938	Homo sapiens	Inihibition	%	24.0
	5120116	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccccn2)nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644615	=	Inhibition	%	5.0	CHEMBL5938	Homo sapiens	INH	%	5.0
	5120184	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644618	=	Inhibition	%	15.0	CHEMBL5938	Homo sapiens	INH	%	15.0
	5120207	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(C2CCOCC2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644639	=	Inhibition	%	26.0	CHEMBL5938	Homo sapiens	INH	%	26.0
	5120219	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCOCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644620	=	Inhibition	%	33.0	CHEMBL5938	Homo sapiens	INH	%	33.0
	5120236	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1[nH]nc(-c2ccnc(NC3CCCOC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644619	=	Inhibition	%	62.0	CHEMBL5938	Homo sapiens	INH	%	62.0
	5121136	CHEMBL1646655	Inhibition of human Snk at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	113.0	CHEMBL5938	Homo sapiens	INH	%	113.0
	5139774	CHEMBL1648813	Inhibition of PLK2 at 10 uM after 60 mins by TR-FRET assay	B	O=c1n(Cc2ccncc2)nc(-c2ccnc(NC3CCCCC3)c2)n1-c1ccc2ccccc2c1		CHEMBL1644642	=	Inhibition	%	0.0	CHEMBL5938	Homo sapiens	INH	%	0.0
Not Active	5220323	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	O=C1NCCCc2c1oc1ccc(O)cc21		CHEMBL1450770		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220324	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	O=C1NCCCc2c1[nH]c1ccc(O)cc21		CHEMBL1672570		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220325	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	O=C1NCCSc2c1sc1ccc(O)cc21		CHEMBL1672571		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220326	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	COc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL319170		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220327	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	[N-]=[N+]=Nc1ccc2sc3c(c2c1)SCCNC3=O		CHEMBL1672572		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220328	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	O=C1NCCCSc2c1sc1ccc(O)cc21		CHEMBL1672573		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220329	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	COc1ccc2sc3c(c2c1)SCCCNC3=O		CHEMBL1672574		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	5220330	CHEMBL1681593	Inhibition of PLK2 at < 10 uM by TR-FRET assay	B	COc1ncc2sc3c(c2n1)SCCNC3=O		CHEMBL1672575		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	5243770	CHEMBL1685874	Inhibition of Snk at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	78.0	CHEMBL5938	Homo sapiens	INH	%	78.0
	5243878	CHEMBL1686090	Inhibition of Snk at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	87.0	CHEMBL5938	Homo sapiens	INH	%	87.0
	5243991	CHEMBL1685874	Inhibition of Snk at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	90.0	CHEMBL5938	Homo sapiens	INH	%	90.0
	5244099	CHEMBL1686090	Inhibition of Snk at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	76.0	CHEMBL5938	Homo sapiens	INH	%	76.0
	5244972	CHEMBL1685874	Inhibition of Snk at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	89.0	CHEMBL5938	Homo sapiens	INH	%	89.0
	5245080	CHEMBL1686090	Inhibition of Snk at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	76.0	CHEMBL5938	Homo sapiens	INH	%	76.0
	5245231	CHEMBL1685874	Inhibition of Snk at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	91.0	CHEMBL5938	Homo sapiens	INH	%	91.0
	5246061	CHEMBL1686090	Inhibition of Snk at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	97.0	CHEMBL5938	Homo sapiens	INH	%	97.0
	5249443	CHEMBL1686794	Inhibition of PLK2 at 10 uM	B	O=C(Cc1cccc2cnccc12)Nc1scc(Cl)c1-c1ncn[nH]1		CHEMBL1682017	=	Inhibition	%	1.0	CHEMBL5938	Homo sapiens	INH	%	1.0
	6197967	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1272140	=	IC50	nM	3519.0	CHEMBL5938	Homo sapiens	IC50	uM	3.519
	6197968	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CC=C(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1774327	=	IC50	nM	2254.0	CHEMBL5938	Homo sapiens	IC50	uM	2.254
	6197969	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCC(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)cn3C)CC4)c2)CC1		CHEMBL1774328	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6197970	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN(C)CCCN1CCC(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1774329	=	IC50	nM	3855.0	CHEMBL5938	Homo sapiens	IC50	uM	3.855
	6197971	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(NC(=O)[C@@H]4CCCN4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1774330	=	IC50	nM	1453.0	CHEMBL5938	Homo sapiens	IC50	uM	1.453
	6197972	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CCN(CC)CCN(C)c1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL1774331	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6197973	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(NC4CCCN4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1774332	=	IC50	nM	762.0	CHEMBL5938	Homo sapiens	IC50	uM	0.762
	6197974	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1269042	=	IC50	nM	1280.0	CHEMBL5938	Homo sapiens	IC50	uM	1.28
	6197975	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(CCCNc2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1774333	=	IC50	nM	1364.0	CHEMBL5938	Homo sapiens	IC50	uM	1.364
	6197976	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCCC1CCNc1ccc(OC(F)(F)F)c(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)c1		CHEMBL1271535	=	IC50	nM	429.0	CHEMBL5938	Homo sapiens	IC50	uM	0.429
	6197977	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)[C@@H](CO)C1		CHEMBL1774334	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6197978	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)[C@H](CO)C1		CHEMBL1774335	=	IC50	nM	1494.0	CHEMBL5938	Homo sapiens	IC50	uM	1.494
	6197979	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCC(C(=O)Nc2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1774336	=	IC50	nM	1499.0	CHEMBL5938	Homo sapiens	IC50	uM	1.499
	6198026	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6198027	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCN)CC4)c2)CC1		CHEMBL1774337	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6198028	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCOC3CCOCC3)CC4)c2)CC1		CHEMBL1774338	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6198029	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCCN)CC4)c2)CC1		CHEMBL1774339	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6198030	CHEMBL1777512	Inhibition of PLK2 assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN(C)CCCn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1774340	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	6221239	CHEMBL1786864	Inhibition of PLK2 at 10 uM	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	73.0	CHEMBL5938	Homo sapiens	INH	%	73.0
	6340937	CHEMBL1827261	Activity of PLK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	92.0	CHEMBL5938	Homo sapiens	Activity	%	92.0
	6353472	CHEMBL1825784	Inhibition of PLK2 at 10 uM	B	O=C(Cn1c(=O)ccc2cc(C(F)(F)F)ccc21)Nc1scc(Br)c1-c1ncn[nH]1		CHEMBL1822146	=	Inhibition	%	10.0	CHEMBL5938	Homo sapiens	INH	%	10.0
	7567462	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7567950	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7568418	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7568850	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7569453	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7569925	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7570388	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	8300.0	CHEMBL5938	Homo sapiens	Kd	nM	8300.0
	7570815	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	4700.0	CHEMBL5938	Homo sapiens	Kd	nM	4700.0
	7570969	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7571426	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7571902	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1500.0	CHEMBL5938	Homo sapiens	Kd	nM	1500.0
	7572365	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7572781	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1200.0	CHEMBL5938	Homo sapiens	Kd	nM	1200.0
	7572950	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	0.81	CHEMBL5938	Homo sapiens	Kd	nM	0.81
	7573407	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7573883	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7574352	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7574760	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7574928	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7575389	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7575860	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7576902	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7577361	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7577867	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7578272	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2400.0	CHEMBL5938	Homo sapiens	Kd	nM	2400.0
	7578910	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7579284	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7579734	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7579766	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7580235	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1400.0	CHEMBL5938	Homo sapiens	Kd	nM	1400.0
	7580638	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7581268	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7581653	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7582127	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7582591	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7582991	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7584014	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7584485	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7584947	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	34.0	CHEMBL5938	Homo sapiens	Kd	nM	34.0
	7585351	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7585502	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7585910	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7586356	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7586827	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7587281	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7587463	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7587882	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7588335	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7588806	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7589257	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7589428	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7589852	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	330.0	CHEMBL5938	Homo sapiens	Kd	nM	330.0
	7590319	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7590793	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7591401	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7591823	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	570.0	CHEMBL5938	Homo sapiens	Kd	nM	570.0
	7592295	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	500.0	CHEMBL5938	Homo sapiens	Kd	nM	500.0
	7592768	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7592779	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7593368	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7593803	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7594275	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7594758	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	960.0	CHEMBL5938	Homo sapiens	Kd	nM	960.0
	7595336	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7595780	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7596283	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7596730	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7597308	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7597761	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7597792	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7598262	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5938	Homo sapiens	Kd	nM	10000.0
	7598704	CHEMBL1908760	Binding constant for PLK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	200.0	CHEMBL5938	Homo sapiens	Kd	nM	200.0
	7922698	CHEMBL1918448	Inhibition of human recombinant PLK2 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	21.0	CHEMBL5938	Homo sapiens	INH	%	21.0
	7961135	CHEMBL1931549	Inhibition of PLK2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL5938	Homo sapiens	IC50	uM	30.0
	7961136	CHEMBL1931549	Inhibition of PLK2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL5938	Homo sapiens	IC50	uM	30.0
	7984729	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4C)n3)c2)CC1		CHEMBL1933576	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984730	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CC(F)(F)F)n3)c2)CC1		CHEMBL1933577	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984731	CHEMBL1936402	Inhibition of PLK2	B	Cn1cc(C(N)=O)cc1-c1ccnc(Nc2cc(N3CCNCC3)ccc2OC(F)(F)F)n1		CHEMBL1933578	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984732	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CCO)n3)c2)CC1		CHEMBL1933579	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984733	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc(C(N)=O)cn4CCOC4CCCCO4)n3)c2)CC1		CHEMBL1933580	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984734	CHEMBL1936402	Inhibition of PLK2	B	Cn1cc(C(N)=O)cc1-c1ccnc(Nc2cc(N3CCN(C(=O)OC(C)(C)C)CC3)ccc2OC(F)(F)F)n1		CHEMBL1933581	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984735	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCNC5=O)n3)c2)CC1		CHEMBL1933582	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984736	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4CC(F)(F)F)CCNC5=O)n3)c2)CC1		CHEMBL1933583	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984737	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4CCO)CCNC5=O)n3)c2)CC1		CHEMBL1933584	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	7984738	CHEMBL1936402	Inhibition of PLK2	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3nccc(-c4cc5c(n4C)CCN(C(=O)OC(C)(C)C)C5=O)n3)c2)CC1		CHEMBL1933585	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
Not Determined	7984772	CHEMBL1936402	Inhibition of PLK2	B	NC(=O)c1c[nH]c(-c2ccnc(N)n2)c1		CHEMBL1933575		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Determined	7984773	CHEMBL1936402	Inhibition of PLK2	B	Nc1nccc(-c2cc3c([nH]2)CCNC3=O)n1		CHEMBL402272		IC50			CHEMBL5938	Homo sapiens	IC50		
	10839470	CHEMBL2015501	Inhibition of PLK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	15.0	CHEMBL5938	Homo sapiens	INH	%	15.0
	12047328	CHEMBL2157439	Inhibition of PLK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.2	CHEMBL5938	Homo sapiens	INH	%	6.2
	12172256	CHEMBL2212486	Inhibition of PLK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	69.0	CHEMBL5938	Homo sapiens	Activity	%	69.0
	12195465	CHEMBL2210940	Inhibition of recombinant PLK2 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	2.0	CHEMBL5938	Homo sapiens	Ki	nM	2.0
	12261494	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261495	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261496	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261497	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	111.0	CHEMBL5938	Homo sapiens	Residual Activity	%	111.0
	12261498	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261499	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	110.0	CHEMBL5938	Homo sapiens	Residual Activity	%	110.0
	12261500	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261501	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	109.0	CHEMBL5938	Homo sapiens	Residual Activity	%	109.0
	12261502	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261503	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261504	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261505	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261506	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261507	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261508	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261509	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261510	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12261511	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261512	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261513	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	49.0	CHEMBL5938	Homo sapiens	Residual Activity	%	49.0
	12261514	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261515	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261516	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261517	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	109.0	CHEMBL5938	Homo sapiens	Residual Activity	%	109.0
	12261518	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261519	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261520	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12261521	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261522	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261523	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261524	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261525	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261526	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12261527	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261528	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261529	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	110.0	CHEMBL5938	Homo sapiens	Residual Activity	%	110.0
	12261530	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261531	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261532	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261533	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261534	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL5938	Homo sapiens	Residual Activity	%	109.0
	12261535	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261536	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261537	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12261538	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	72.0	CHEMBL5938	Homo sapiens	Residual Activity	%	72.0
	12261539	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261540	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261541	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261542	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	73.0	CHEMBL5938	Homo sapiens	Residual Activity	%	73.0
	12261543	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL5938	Homo sapiens	Residual Activity	%	111.0
	12261544	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261545	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261546	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	49.0	CHEMBL5938	Homo sapiens	Residual Activity	%	49.0
	12261547	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261548	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261549	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261550	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	112.0	CHEMBL5938	Homo sapiens	Residual Activity	%	112.0
	12261551	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	113.0	CHEMBL5938	Homo sapiens	Residual Activity	%	113.0
	12261552	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261553	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261554	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261555	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261556	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261557	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261558	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL5938	Homo sapiens	Residual Activity	%	116.0
	12261559	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261560	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261561	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261562	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261563	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261564	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261565	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261566	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	113.0	CHEMBL5938	Homo sapiens	Residual Activity	%	113.0
	12261567	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261568	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261569	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261570	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	112.0	CHEMBL5938	Homo sapiens	Residual Activity	%	112.0
	12261571	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261572	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261573	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	69.0	CHEMBL5938	Homo sapiens	Residual Activity	%	69.0
	12261574	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261575	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12261576	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261577	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261578	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261579	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	109.0	CHEMBL5938	Homo sapiens	Residual Activity	%	109.0
	12261580	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261581	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	116.0	CHEMBL5938	Homo sapiens	Residual Activity	%	116.0
	12261582	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261583	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261584	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12261585	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261586	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12261587	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261588	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261589	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261590	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12261591	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261592	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261593	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261594	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	38.0	CHEMBL5938	Homo sapiens	Residual Activity	%	38.0
	12261595	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	72.0	CHEMBL5938	Homo sapiens	Residual Activity	%	72.0
	12261596	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261597	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261598	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12261599	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261600	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261601	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261602	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261603	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261604	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261605	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261606	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	82.0	CHEMBL5938	Homo sapiens	Residual Activity	%	82.0
	12261607	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261608	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12261609	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261610	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261611	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	110.0	CHEMBL5938	Homo sapiens	Residual Activity	%	110.0
	12261612	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261613	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	108.0	CHEMBL5938	Homo sapiens	Residual Activity	%	108.0
	12261614	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261615	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12261616	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	61.0	CHEMBL5938	Homo sapiens	Residual Activity	%	61.0
	12261617	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261618	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	86.0	CHEMBL5938	Homo sapiens	Residual Activity	%	86.0
	12261619	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261620	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261621	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	110.0	CHEMBL5938	Homo sapiens	Residual Activity	%	110.0
	12261622	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261623	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	71.0	CHEMBL5938	Homo sapiens	Residual Activity	%	71.0
	12261624	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12261625	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261626	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12261627	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261628	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12261629	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	79.0	CHEMBL5938	Homo sapiens	Residual Activity	%	79.0
	12261630	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261631	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261632	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261633	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261634	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261635	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	109.0	CHEMBL5938	Homo sapiens	Residual Activity	%	109.0
	12261636	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261637	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	82.0	CHEMBL5938	Homo sapiens	Residual Activity	%	82.0
	12261638	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261639	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261640	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261641	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261642	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261643	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	112.0	CHEMBL5938	Homo sapiens	Residual Activity	%	112.0
	12261644	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261645	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	39.0	CHEMBL5938	Homo sapiens	Residual Activity	%	39.0
	12261646	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261647	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261648	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261649	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261650	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261651	CHEMBL2219193	Millipore: Percentage of residual kinase activity of PLK2 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261652	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	67.0	CHEMBL5938	Homo sapiens	Residual Activity	%	67.0
	12261653	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261654	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12261655	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12261656	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12261657	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261658	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	65.0	CHEMBL5938	Homo sapiens	Residual Activity	%	65.0
	12261659	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	82.0	CHEMBL5938	Homo sapiens	Residual Activity	%	82.0
	12261660	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261661	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261662	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261663	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261664	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261665	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261666	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	86.0	CHEMBL5938	Homo sapiens	Residual Activity	%	86.0
	12261667	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261668	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12261669	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	71.0	CHEMBL5938	Homo sapiens	Residual Activity	%	71.0
	12261670	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261671	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	44.0	CHEMBL5938	Homo sapiens	Residual Activity	%	44.0
	12261672	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261673	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12261674	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261675	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12261676	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12261677	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	88.0	CHEMBL5938	Homo sapiens	Residual Activity	%	88.0
	12261678	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	78.0	CHEMBL5938	Homo sapiens	Residual Activity	%	78.0
	12261679	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12261680	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261681	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12261682	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12261683	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261684	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12261685	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12261686	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12261687	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12261688	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	80.0	CHEMBL5938	Homo sapiens	Residual Activity	%	80.0
	12261689	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12261690	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12261691	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12261692	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12261693	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261694	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12261695	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	43.0	CHEMBL5938	Homo sapiens	Residual Activity	%	43.0
	12261696	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	35.0	CHEMBL5938	Homo sapiens	Residual Activity	%	35.0
	12261697	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12261698	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12261699	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	84.0	CHEMBL5938	Homo sapiens	Residual Activity	%	84.0
	12261700	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	34.0	CHEMBL5938	Homo sapiens	Residual Activity	%	34.0
	12261701	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12261702	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	84.0	CHEMBL5938	Homo sapiens	Residual Activity	%	84.0
	12261703	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261704	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	17.0	CHEMBL5938	Homo sapiens	Residual Activity	%	17.0
	12261705	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261706	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12261707	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12261708	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12261709	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12261710	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12261711	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	82.0	CHEMBL5938	Homo sapiens	Residual Activity	%	82.0
	12261712	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12261713	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	86.0	CHEMBL5938	Homo sapiens	Residual Activity	%	86.0
	12261714	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	63.0	CHEMBL5938	Homo sapiens	Residual Activity	%	63.0
	12261715	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12261716	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12261717	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12263364	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12263365	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263366	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	73.0	CHEMBL5938	Homo sapiens	Residual Activity	%	73.0
	12263367	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12263368	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12263369	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	73.0	CHEMBL5938	Homo sapiens	Residual Activity	%	73.0
	12263370	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	88.0	CHEMBL5938	Homo sapiens	Residual Activity	%	88.0
	12263371	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	105.0	CHEMBL5938	Homo sapiens	Residual Activity	%	105.0
	12263372	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263373	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	74.0	CHEMBL5938	Homo sapiens	Residual Activity	%	74.0
	12263374	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263375	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	58.0	CHEMBL5938	Homo sapiens	Residual Activity	%	58.0
	12263376	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12263377	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	28.0	CHEMBL5938	Homo sapiens	Residual Activity	%	28.0
	12263378	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12263379	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	60.0	CHEMBL5938	Homo sapiens	Residual Activity	%	60.0
	12263380	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12263381	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12263382	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12263383	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12263384	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12263385	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	103.0	CHEMBL5938	Homo sapiens	Residual Activity	%	103.0
	12263386	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263387	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	82.0	CHEMBL5938	Homo sapiens	Residual Activity	%	82.0
	12263388	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12263389	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263390	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	56.0	CHEMBL5938	Homo sapiens	Residual Activity	%	56.0
	12263391	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12263392	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL5938	Homo sapiens	Residual Activity	%	102.0
	12263393	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	113.0	CHEMBL5938	Homo sapiens	Residual Activity	%	113.0
	12263394	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12263395	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12263396	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12263397	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12263398	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	38.0	CHEMBL5938	Homo sapiens	Residual Activity	%	38.0
	12263399	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	36.0	CHEMBL5938	Homo sapiens	Residual Activity	%	36.0
	12263400	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12263401	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	80.0	CHEMBL5938	Homo sapiens	Residual Activity	%	80.0
	12263402	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263403	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL5938	Homo sapiens	Residual Activity	%	88.0
	12263404	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12263405	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12263406	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12263407	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	91.0	CHEMBL5938	Homo sapiens	Residual Activity	%	91.0
	12263408	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12263409	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12263410	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	87.0	CHEMBL5938	Homo sapiens	Residual Activity	%	87.0
	12263411	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	80.0	CHEMBL5938	Homo sapiens	Residual Activity	%	80.0
	12263412	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	93.0	CHEMBL5938	Homo sapiens	Residual Activity	%	93.0
	12263413	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12263414	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	73.0	CHEMBL5938	Homo sapiens	Residual Activity	%	73.0
	12263415	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	99.0	CHEMBL5938	Homo sapiens	Residual Activity	%	99.0
	12263416	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	88.0	CHEMBL5938	Homo sapiens	Residual Activity	%	88.0
	12263417	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12263418	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	86.0	CHEMBL5938	Homo sapiens	Residual Activity	%	86.0
	12263419	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	54.0	CHEMBL5938	Homo sapiens	Residual Activity	%	54.0
	12263420	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	22.0	CHEMBL5938	Homo sapiens	Residual Activity	%	22.0
	12263421	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL5938	Homo sapiens	Residual Activity	%	97.0
	12263422	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	76.0	CHEMBL5938	Homo sapiens	Residual Activity	%	76.0
	12263423	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263424	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	86.0	CHEMBL5938	Homo sapiens	Residual Activity	%	86.0
	12263425	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12263426	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263427	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	26.0	CHEMBL5938	Homo sapiens	Residual Activity	%	26.0
	12263428	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12263429	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263430	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	61.0	CHEMBL5938	Homo sapiens	Residual Activity	%	61.0
	12263431	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12263432	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	65.0	CHEMBL5938	Homo sapiens	Residual Activity	%	65.0
	12263433	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	34.0	CHEMBL5938	Homo sapiens	Residual Activity	%	34.0
	12263434	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	68.0	CHEMBL5938	Homo sapiens	Residual Activity	%	68.0
	12263435	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	90.0	CHEMBL5938	Homo sapiens	Residual Activity	%	90.0
	12263436	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	96.0	CHEMBL5938	Homo sapiens	Residual Activity	%	96.0
	12263437	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	89.0	CHEMBL5938	Homo sapiens	Residual Activity	%	89.0
	12263438	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12263439	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL5938	Homo sapiens	Residual Activity	%	107.0
	12263440	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	94.0	CHEMBL5938	Homo sapiens	Residual Activity	%	94.0
	12263441	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	85.0	CHEMBL5938	Homo sapiens	Residual Activity	%	85.0
	12263442	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12263443	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	92.0	CHEMBL5938	Homo sapiens	Residual Activity	%	92.0
	12263444	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12263445	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	71.0	CHEMBL5938	Homo sapiens	Residual Activity	%	71.0
	12263446	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263447	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	100.0	CHEMBL5938	Homo sapiens	Residual Activity	%	100.0
	12263448	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	55.0	CHEMBL5938	Homo sapiens	Residual Activity	%	55.0
	12263449	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	25.0	CHEMBL5938	Homo sapiens	Residual Activity	%	25.0
	12263450	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL5938	Homo sapiens	Residual Activity	%	98.0
	12263451	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	95.0	CHEMBL5938	Homo sapiens	Residual Activity	%	95.0
	12263452	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	106.0	CHEMBL5938	Homo sapiens	Residual Activity	%	106.0
	12263453	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12263454	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	104.0	CHEMBL5938	Homo sapiens	Residual Activity	%	104.0
	12263455	CHEMBL2219194	Millipore: Percentage of residual kinase activity of PLK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	101.0	CHEMBL5938	Homo sapiens	Residual Activity	%	101.0
	12668282	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(N3CCOCC3)ccc12		CHEMBL2333120	=	Inhibition	%	6.0	CHEMBL5938	Homo sapiens	INH	%	6.0
	12668283	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3cn[nH]c3)cc12		CHEMBL2333115	=	Inhibition	%	80.0	CHEMBL5938	Homo sapiens	INH	%	80.0
	12668284	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2ccc(-c3ccncc3)cc12		CHEMBL2333114	=	Inhibition	%	51.0	CHEMBL5938	Homo sapiens	INH	%	51.0
	12668285	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)nnc2cc(-c3ccncc3)ccc12		CHEMBL2333112	=	Inhibition	%	30.0	CHEMBL5938	Homo sapiens	INH	%	30.0
	12668286	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CS(=O)(=O)c1ccc(-c2ccc3c(NC4CCC4)c(C(N)=O)nnc3c2)cc1		CHEMBL2333129	=	Inhibition	%	11.0	CHEMBL5938	Homo sapiens	INH	%	11.0
	12668287	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	C[C@@H](Nc1c(C(N)=O)nnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12)C1CC1		CHEMBL2333128	=	Inhibition	%	17.0	CHEMBL5938	Homo sapiens	INH	%	17.0
	12668288	CHEMBL2345066	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC(C)Nc1c(C(N)=O)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2333125	=	Inhibition	%	7.0	CHEMBL5938	Homo sapiens	INH	%	7.0
	12723648	CHEMBL2350746	Inhibition of PLK2 (unknown origin) at 10 uM by single point assay	B	C[C@@H](Nc1c(C#N)cnc2cc(-c3ccc(-n4ccoc4=O)cc3)ccc12)C1CC1		CHEMBL2347818	=	Inhibition	%	54.0	CHEMBL5938	Homo sapiens	INH	%	54.0
	12724738	CHEMBL2352267	Inhibition of PLK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3cnn(C)c3)ccc12		CHEMBL2347824	=	Inhibition	%	89.0	CHEMBL5938	Homo sapiens	INH	%	89.0
	12724739	CHEMBL2352267	Inhibition of PLK2 (unknown origin) at 1 uM by single point assay	B	CC(C)Nc1c(C#N)cnc2cc(-c3ccc(S(C)(=O)=O)cc3)ccc12		CHEMBL2347823	=	Inhibition	%	73.0	CHEMBL5938	Homo sapiens	INH	%	73.0
	12727667	CHEMBL2351131	Inhibition of PLK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	69.0	CHEMBL5938	Homo sapiens	Activity	%	69.0
	12728953	CHEMBL2349888	Inhibition of PLK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5938	Homo sapiens	Activity	%	99.0
	12729841	CHEMBL2352428	Inhibition of PLK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	95.0	CHEMBL5938	Homo sapiens	Activity	%	95.0
	12730096	CHEMBL2351131	Inhibition of PLK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL5938	Homo sapiens	Activity	%	98.0
Not Active	13310831	CHEMBL2383282	Inhibition of Plk2 polo-box domain (unknown origin) assessed as inhibition of 5-carboxyfluorescein-Ahx-GPMQTS-pT-PKNG binding after 10 mins by fluorescence polarization assay	B	CC(=O)n1cc(CCNC(=O)CCCCCN2CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3cncn3CCCCCCCCc3ccccc3)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](C(N)=O)CSCC2=O)c2ccccc21		CHEMBL2380764		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	13310832	CHEMBL2383282	Inhibition of Plk2 polo-box domain (unknown origin) assessed as inhibition of 5-carboxyfluorescein-Ahx-GPMQTS-pT-PKNG binding after 10 mins by fluorescence polarization assay	B	CC(=O)n1cc(CCNC(=O)CCCCCN2CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc3c[nH]cn3)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](C(N)=O)CSCC2=O)c2ccccc21		CHEMBL2380660		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	13374387	CHEMBL2406518	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	100.0	CHEMBL5938	Homo sapiens	INH	%	100.0
	13375973	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1c1cncnc1		CHEMBL2401962	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375974	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CCC1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3ccccn3)nc2N1c1cnn(C)c1		CHEMBL2401957	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375975	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1c1cn[nH]c1		CHEMBL2402085	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375976	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1[C@H]1CCOC1		CHEMBL2402084	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375977	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1C1CCOCC1		CHEMBL2402083	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375978	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375979	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cnn(C)c1		CHEMBL2402080	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375980	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cc[nH]n1		CHEMBL2402079	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375981	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cn[nH]c1		CHEMBL2402078	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375982	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1[C@H]1CCOC1		CHEMBL2401973	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375983	CHEMBL2406134	Ratio of IC50 for Plk2 (unknown origin) transfected in HEK293 cells to IC50 for GST-tagged Plk2 (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1CCC(F)(F)F		CHEMBL2401967	=	Ratio IC50		50.0	CHEMBL5938	Homo sapiens	Ratio IC50		50.0
	13375984	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1c1cn[nH]c1		CHEMBL2402085	=	IC50	nM	5820.0	CHEMBL5938	Homo sapiens	IC50	uM	5.82
	13375985	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1c1cncnc1		CHEMBL2401962	=	IC50	nM	3870.0	CHEMBL5938	Homo sapiens	IC50	uM	3.87
	13375986	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1[C@H]1CCOC1		CHEMBL2402084	=	IC50	nM	3190.0	CHEMBL5938	Homo sapiens	IC50	uM	3.19
	13375987	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1C1CCOCC1		CHEMBL2402083	=	IC50	nM	2990.0	CHEMBL5938	Homo sapiens	IC50	uM	2.99
	13375988	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1CCC(F)(F)F		CHEMBL2401967	=	IC50	nM	2560.0	CHEMBL5938	Homo sapiens	IC50	uM	2.56
	13375989	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1[C@H]1CCOC1		CHEMBL2401973	=	IC50	nM	2050.0	CHEMBL5938	Homo sapiens	IC50	uM	2.05
	13375990	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cn[nH]c1		CHEMBL2402078	=	IC50	nM	1870.0	CHEMBL5938	Homo sapiens	IC50	uM	1.87
	13375991	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cnn(C)c1		CHEMBL2402080	=	IC50	nM	780.0	CHEMBL5938	Homo sapiens	IC50	uM	0.78
	13375992	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cc[nH]n1		CHEMBL2402079	=	IC50	nM	740.0	CHEMBL5938	Homo sapiens	IC50	uM	0.74
	13375993	CHEMBL2406136	Inhibition of Plk2 (unknown origin) transfected in HEK293 cells assessed as inhibition of alpha-synuclein phosphorylation at ser129 after 2 hrs by ELISA	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	IC50	nM	480.0	CHEMBL5938	Homo sapiens	IC50	uM	0.48
	13377374	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC(C)N1c2nc(-n3ccnc3-c3ccc(F)cc3)ncc2N(C)C(=O)C1(C)C		CHEMBL2401961	=	IC50	nM	2710.0	CHEMBL5938	Homo sapiens	IC50	uM	2.71
	13377375	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC(C)N1c2nc(-n3ccnc3-c3ccc(F)cc3)ncc2N(C)C(=O)C12CCC2		CHEMBL2401960	=	IC50	nM	1150.0	CHEMBL5938	Homo sapiens	IC50	uM	1.15
	13377376	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1C1COC1		CHEMBL2401970	=	IC50	nM	1040.0	CHEMBL5938	Homo sapiens	IC50	uM	1.04
	13377377	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccnn1C		CHEMBL2402082	=	IC50	nM	532.0	CHEMBL5938	Homo sapiens	IC50	uM	0.532
	13377378	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3ccccn3)nc2N1c1cnn(C)c1		CHEMBL2401957	=	IC50	nM	168.0	CHEMBL5938	Homo sapiens	IC50	uM	0.168
	13377379	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1c1cnn(C)c1		CHEMBL2402086	=	IC50	nM	130.0	CHEMBL5938	Homo sapiens	IC50	uM	0.13
	13377380	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CN1C(=O)C(CC(F)(F)F)N(CCC(F)(F)F)c2nc(-n3ccnc3-c3ccc(F)cc3)ncc21		CHEMBL2401958	=	IC50	nM	120.0	CHEMBL5938	Homo sapiens	IC50	uM	0.12
	13377381	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3ccc(F)cc3F)nc2N1c1cnn(C)c1		CHEMBL2401956	=	IC50	nM	103.0	CHEMBL5938	Homo sapiens	IC50	uM	0.103
	13377382	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1c1cn[nH]c1		CHEMBL2402085	=	IC50	nM	92.0	CHEMBL5938	Homo sapiens	IC50	uM	0.092
	13377383	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1C(C)C		CHEMBL2401964	=	IC50	nM	60.0	CHEMBL5938	Homo sapiens	IC50	uM	0.06
	13377384	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1c1cncnc1		CHEMBL2402077	=	IC50	nM	44.0	CHEMBL5938	Homo sapiens	IC50	uM	0.044
	13377385	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1CCC(F)(F)F		CHEMBL2401967	=	IC50	nM	42.0	CHEMBL5938	Homo sapiens	IC50	uM	0.042
	13377386	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1[C@H]1CCOC1		CHEMBL2402084	=	IC50	nM	39.0	CHEMBL5938	Homo sapiens	IC50	uM	0.039
	13377387	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-c3cn[nH]c3-c3nccs3)nc2N1C1CCOCC1		CHEMBL2402083	=	IC50	nM	36.0	CHEMBL5938	Homo sapiens	IC50	uM	0.036
	13377388	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1[C@H]1CCOC1		CHEMBL2401973	=	IC50	nM	33.0	CHEMBL5938	Homo sapiens	IC50	uM	0.033
	13377389	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccc(C#N)cc1		CHEMBL2402076	=	IC50	nM	31.0	CHEMBL5938	Homo sapiens	IC50	uM	0.031
	13377390	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1(C)C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1CCC(F)(F)F		CHEMBL2401959	=	IC50	nM	30.0	CHEMBL5938	Homo sapiens	IC50	uM	0.03
	13377391	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1C(C)C		CHEMBL2401965	=	IC50	nM	25.0	CHEMBL5938	Homo sapiens	IC50	uM	0.025
	13377392	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cnn(C)c1		CHEMBL2402080	=	IC50	nM	21.0	CHEMBL5938	Homo sapiens	IC50	uM	0.021
	13377393	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1[C@@H]1CCOC1		CHEMBL2401972	=	IC50	nM	21.0	CHEMBL5938	Homo sapiens	IC50	uM	0.021
	13377394	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1c1ccccc1		CHEMBL2401974	=	IC50	nM	17.0	CHEMBL5938	Homo sapiens	IC50	uM	0.017
	13377395	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccc(F)cc1		CHEMBL2401975	=	IC50	nM	15.0	CHEMBL5938	Homo sapiens	IC50	uM	0.015
	13377396	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1C1CCC(F)(F)C1		CHEMBL2401968	=	IC50	nM	13.0	CHEMBL5938	Homo sapiens	IC50	uM	0.013
	13377397	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cn[nH]c1		CHEMBL2402078	=	IC50	nM	12.0	CHEMBL5938	Homo sapiens	IC50	uM	0.012
	13377398	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1C1CC(F)(F)C1		CHEMBL2401969	=	IC50	nM	12.0	CHEMBL5938	Homo sapiens	IC50	uM	0.012
	13377399	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CCC1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1cc[nH]n1		CHEMBL2402079	=	IC50	nM	9.0	CHEMBL5938	Homo sapiens	IC50	uM	0.009
	13377400	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1CCC(F)(F)F		CHEMBL2401966	=	IC50	nM	9.0	CHEMBL5938	Homo sapiens	IC50	uM	0.009
	13377401	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1[C@H]1CCOC1		CHEMBL2401971	=	IC50	nM	8.0	CHEMBL5938	Homo sapiens	IC50	uM	0.008
	13377402	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	IC50	nM	7.0	CHEMBL5938	Homo sapiens	IC50	uM	0.007
	13377403	CHEMBL2406852	Inhibition of GST-tagged Plk2 (unknown origin) assessed as inhibition of DEKTDDED phosphorylation at Thr1342 after 60 mins by TR-FRET assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccccc3)nc2N1C1CCCC1		CHEMBL2401963	=	IC50	nM	5.0	CHEMBL5938	Homo sapiens	IC50	uM	0.005
	13395201	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccc(C(=O)O)cc3)n[nH]c2c1		CHEMBL2407744	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395202	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL2407900	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395203	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CN1CCN(c2ccc(/C=C/c3n[nH]c4cc(/C=C5/C(=O)Nc6ccccc65)ccc34)cn2)CC1		CHEMBL2407899	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395204	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccc(CN(C)C)cc4)n[nH]c3c1)C(=O)N2		CHEMBL2407898	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395205	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc(/C=C4/C(=O)Nc5ccccc54)ccc23)cc1		CHEMBL2407897	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395206	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccccc3)n[nH]c2c1		CHEMBL2407896	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395207	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccc(O)cc2/C1=C\c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL2407895	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395208	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccncc4)n[nH]c3c1)C(=O)N2		CHEMBL2407894	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395209	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	Cc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4ccncc4)n[nH]c3c1)C(=O)N2		CHEMBL2407893	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13395210	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL2407750	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396081	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL2407749	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396082	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4cccnc4)n[nH]c3c1)C(=O)N2		CHEMBL2407748	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396083	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CCc1ccc2c(c1)/C(=C\c1ccc3c(/C=C/c4cccnc4)n[nH]c3c1)C(=O)N2		CHEMBL2407747	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396084	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3cccnc3)n[nH]c2c1		CHEMBL2407746	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396085	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL2407745	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396086	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CC(=O)Nc1ccc2c(c1)NC(=O)/C2=C/c1ccc2cn[nH]c2c1		CHEMBL2407919	=	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396087	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CC(=O)Nc1ccc2c(c1)/C(=C\c1ccc3cn[nH]c3c1)C(=O)N2		CHEMBL2407918	=	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
Not Determined	13396088	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CNC(=O)c1ccc2c(c1)/C(=C\c1ccc3cn[nH]c3c1)C(=O)N2		CHEMBL2407917		IC50			CHEMBL5938	Homo sapiens	IC50		
	13396089	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	COc1ccc2c(c1)/C(=C\c1ccc3cn[nH]c3c1)C(=O)N2		CHEMBL2407916	<	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396090	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2cc(Cl)ccc2/C1=C\c1ccc2cn[nH]c2c1		CHEMBL2407915	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396091	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccc(Cl)cc2/C1=C\c1ccc2cn[nH]c2c1		CHEMBL2407914	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396092	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccc(F)cc2/C1=C/c1ccc2cn[nH]c2c1		CHEMBL2407913	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13396093	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccc(F)cc2/C1=C\c1ccc2cn[nH]c2c1		CHEMBL2407912	=	IC50	nM	4400.0	CHEMBL5938	Homo sapiens	IC50	uM	4.4
	13396094	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2cn[nH]c2c1		CHEMBL2407911	=	IC50	nM	5700.0	CHEMBL5938	Homo sapiens	IC50	uM	5.7
	13396095	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C/c1ccc2[nH]ncc2c1		CHEMBL2407910	=	IC50	nM	1900.0	CHEMBL5938	Homo sapiens	IC50	uM	1.9
	13396096	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2nn[nH]c2c1		CHEMBL2407909	=	IC50	nM	8900.0	CHEMBL5938	Homo sapiens	IC50	uM	8.9
	13396097	CHEMBL2410317	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	13871741	CHEMBL3100777	Inhibition of human Snk assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	83.0	CHEMBL5938	Homo sapiens	Activity	%	83.0
	14585314	CHEMBL3241830	Inhibition of human Plk2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	102.5	CHEMBL5938	Homo sapiens	Activity	%	102.5
	14983173	CHEMBL3385026	Inhibition of PLK2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	100.0	CHEMBL5938	Homo sapiens	INH	%	100.0
	14984415	CHEMBL3384376	Inhibition of PLK2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	63.0	CHEMBL5938	Homo sapiens	INH	%	63.0
	14996595	CHEMBL3364627	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2[C@]12C[C@H]2c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL3353340	>	IC50	nM	100000.0	CHEMBL5938	Homo sapiens	IC50	nM	100000.0
	14996596	CHEMBL3364627	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	CN(C)Cc1ccc(/C=C/c2n[nH]c3cc([C@@H]4C[C@@]45C(=O)Nc4ccccc45)ccc23)cc1		CHEMBL3353347	>	IC50	nM	100000.0	CHEMBL5938	Homo sapiens	IC50	nM	100000.0
Not Determined	15007923	CHEMBL3367524	Inhibition of PLK2 (unknown origin) by FRET-based homogenous assay	B	CCc1cccc(CC)c1NC(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1		CHEMBL3330260		IC50			CHEMBL5938	Homo sapiens	IC50		
	15007924	CHEMBL3367524	Inhibition of PLK2 (unknown origin) by FRET-based homogenous assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
Not Determined	15007925	CHEMBL3367524	Inhibition of PLK2 (unknown origin) by FRET-based homogenous assay	B	CCc1ccccc1C(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)N(C)C		CHEMBL3330409		IC50			CHEMBL5938	Homo sapiens	IC50		
	15018679	CHEMBL3361571	Inhibition of PLK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	2.3	CHEMBL5938	Homo sapiens	INH	%	2.3
	15061775	CHEMBL3364627	Inhibition of PLK2 (unknown origin) by FRET-based homogeneous assay	B	O=C1Nc2ccccc2/C1=C\c1ccc2c(/C=C/c3ccncc3)n[nH]c2c1		CHEMBL2407749	>	IC50	nM	100000.0	CHEMBL5938	Homo sapiens	IC50	nM	100000.0
	15120759	CHEMBL3372891	Inhibition of Plk2 immunoprecipitated from human HeLa cells using casein substrate after 12 to 26 hrs by autoradiography	B	COc1cc(CNCc2ccncc2)ccc1OCc1ccc(Cl)cc1		CHEMBL3344193	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	15147427	CHEMBL3395145	Inhibition of recombinant Plk2 (unknown origin)	B	O=C(O)Cc1cn(CC(O)CN2CCCC2)c2ccccc12		CHEMBL3394764	>	IC50	nM	50000.0	CHEMBL5938	Homo sapiens	IC50	uM	50.0
	15147428	CHEMBL3395145	Inhibition of recombinant Plk2 (unknown origin)	B	CC1=CC(=O)C(C(C)C)=CC1=O		CHEMBL1672002	=	IC50	nM	14720.0	CHEMBL5938	Homo sapiens	IC50	uM	14.72
Not Active	15193012	CHEMBL3411670	Inhibition of PLK2 (unknown origin) at 50 uM by FRET analysis	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5CCOCC5)cc4)n[nH]c3c1)C(=O)N2C		CHEMBL3408945		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	15193013	CHEMBL3411670	Inhibition of PLK2 (unknown origin) at 50 uM by FRET analysis	B	C[C@H]1CN(Cc2ccc(/C=C/c3n[nH]c4cc([C@@H]5C[C@@]56C(=O)Nc5ccccc56)ccc34)cc2)C[C@@H](C)O1		CHEMBL3408946		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	15193014	CHEMBL3411670	Inhibition of PLK2 (unknown origin) at 50 uM by FRET analysis	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	15211847	CHEMBL3420213	Inhibition of PLK-2 (unknown origin)	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(CN5C[C@H](C)O[C@H](C)C5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL3408947	>	IC50	nM	50000.0	CHEMBL5938	Homo sapiens	IC50	uM	50.0
	15756837	CHEMBL3630946	Inhibition of PLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	2.47	CHEMBL5938	Homo sapiens	INH	%	2.47
	15757886	CHEMBL3630946	Inhibition of PLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.04	CHEMBL5938	Homo sapiens	INH	%	7.04
	15758865	CHEMBL3630946	Inhibition of PLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	1.52	CHEMBL5938	Homo sapiens	INH	%	1.52
273869	16265694	CHEMBL3706119	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	CN[C@H]1CC2OC([C@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(O)=NC4		CHEMBL3975634	=	IC50	nM	813.0	CHEMBL5938	Homo sapiens	IC50	nM	813.0
273836	16317145	CHEMBL3706119	Kinase Inhibition Assay: The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 μM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 μM. Reactions were carried out in 10 μM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.	B	Cn1c(=O)c(Sc2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3702566	=	IC50	nM	201.0	CHEMBL5938	Homo sapiens	IC50	nM	201.0
228398	16344408	CHEMBL3707634	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)nc2N1C1CCCC1		CHEMBL3660143	=	IC50	nM	1130.0	CHEMBL5938	Homo sapiens	IC50	nM	1130.0
	16425415	CHEMBL3749844	Inhibition of PLK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	5.8	CHEMBL5938	Homo sapiens	INH	%	5.8
	16431981	CHEMBL3750020	Inhibition of human PLK2 using casein as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	=	IC50	nM	374.0	CHEMBL5938	Homo sapiens	IC50	uM	0.374
	16432058	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	Cn1c(=O)c(S(=O)(=O)c2ccccc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3746910	=	IC50	nM	1230.0	CHEMBL5938	Homo sapiens	IC50	uM	1.23
	16432059	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2)cc2cnc(Nc3cccc4[nH]ccc34)nc21		CHEMBL3745753	=	IC50	nM	6080.0	CHEMBL5938	Homo sapiens	IC50	uM	6.08
	16432060	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3747002	=	IC50	nM	1070.0	CHEMBL5938	Homo sapiens	IC50	uM	1.07
	16432061	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	Cn1c(=O)c(S(=O)(=O)c2ccc(O)cc2)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3746075	=	IC50	nM	470.0	CHEMBL5938	Homo sapiens	IC50	uM	0.47
	16432062	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	COc1ccc(S(=O)(=O)c2cc3cnc(Nc4ccc5[nH]ccc5c4)nc3n(C)c2=O)cc1		CHEMBL3747595	=	IC50	nM	350.0	CHEMBL5938	Homo sapiens	IC50	uM	0.35
	16432063	CHEMBL3750037	Inhibition of human recombinant PLK2 using recombinant dephosphorylated bovine alpha- casein as substrate after 30 mins by scintillation counting analysis in presence of gamma-32P-ATP	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	=	IC50	nM	310.0	CHEMBL5938	Homo sapiens	IC50	uM	0.31
	16432067	CHEMBL3749350	Binding affinity to human recombinant PLK2 assessed as change in melting temperature after 5 mins by differential scanning fluorometric analysis	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	=	Delta Tm	degrees C	4.1	CHEMBL5938	Homo sapiens	deltaTm	degrees C	4.1
	16432076	CHEMBL3749350	Binding affinity to human recombinant PLK2 assessed as change in melting temperature after 5 mins by differential scanning fluorometric analysis	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Delta Tm	degrees C	12.3	CHEMBL5938	Homo sapiens	deltaTm	degrees C	12.3
	16451586	CHEMBL3761167	Inhibition of PLK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	5.5	CHEMBL5938	Homo sapiens	INH	%	5.5
	16495228	CHEMBL3778871	Inhibition of N-terminal His6-tagged recombinant human SNK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-6.0	CHEMBL5938	Homo sapiens	Activity	%	-6.0
	16496147	CHEMBL3778871	Inhibition of N-terminal His6-tagged recombinant human SNK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-8.0	CHEMBL5938	Homo sapiens	Activity	%	-8.0
	16508937	CHEMBL3778871	Inhibition of N-terminal His6-tagged recombinant human SNK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	5.0	CHEMBL5938	Homo sapiens	Activity	%	5.0
	16613262	CHEMBL3816077	Inhibition of human Plk2 PBD (355 to 685 residues) using 5-carboxyfluorescein-GPMQTSpTPKNG-OH as substrate incubated for 1 hr prior to addition of substrate by fluorescence polarization assay	B	COc1ccc(Br)cc1/C=c1\sc2nc(=O)c(C)nn2c1=O		CHEMBL3814269	=	IC50	nM	1700.0	CHEMBL5938	Homo sapiens	IC50	uM	1.7
	16614610	CHEMBL3815966	Inhibition of human PLK2 at 1 uM using casein as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-4.0	CHEMBL5938	Homo sapiens	INH	%	-4.0
	16618124	CHEMBL3816510	Inhibition of full length recombinant human GST-tagged PLK2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	16815505	CHEMBL3871637	Binding affinity to NT-647 labeled PLK2 polo-box domain (unknown origin) by microscale thermophoresis based fluorescence assay	B	NS(=O)(=O)c1cc(Br)c(NC(=S)NC(=O)c2ccccc2)c(Br)c1	Potential missing data	CHEMBL3894239		Activity			CHEMBL5938	Homo sapiens	Activity		
228397	17616698	CHEMBL3707634	Biochemical Assay: The inhibitory activity of putative kinase inhibitors and the potency of selected compounds were determined using a trans-phosphorylation assay.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	30.0	CHEMBL5938	Homo sapiens	IC50	nM	30.0
	18114805	CHEMBL4025335	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	18201831	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL2207845	=	IC50	nM	130.0	CHEMBL5938	Homo sapiens	IC50	nM	130.0
	18201832	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccc(CCO)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL4092848	=	IC50	nM	310.0	CHEMBL5938	Homo sapiens	IC50	nM	310.0
	18201833	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccc(CCOCc2ccccc2)cc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL4065187	=	IC50	nM	250.0	CHEMBL5938	Homo sapiens	IC50	nM	250.0
	18201834	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1c(F)cccc1Oc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL3956625	=	IC50	nM	290.0	CHEMBL5938	Homo sapiens	IC50	nM	290.0
	18201835	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1c(F)cccc1Oc1cccc(O)c1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL4068949	=	IC50	nM	3400.0	CHEMBL5938	Homo sapiens	IC50	nM	3400.0
	18201836	CHEMBL4043629	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to myc-tagged Plk2 (unknown origin) PBD expressed in HEK-293T cells incubated for 1 hr by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1c(F)cccc1Oc1cccc(OCc2ccccc2)c1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL4080819	=	IC50	nM	3500.0	CHEMBL5938	Homo sapiens	IC50	nM	3500.0
	18203859	CHEMBL4044146	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	18253933	CHEMBL4055251	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	18253934	CHEMBL4055251	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	18282215	CHEMBL4120170	Inhibition of full length recombinant GST-tagged human PLK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	17.3	CHEMBL5938	Homo sapiens	INH	%	17.3
	18282534	CHEMBL4120170	Inhibition of full length recombinant GST-tagged human PLK2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	2.7	CHEMBL5938	Homo sapiens	INH	%	2.7
	18298080	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(C)=O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4127365	=	IC50	nM	13370.0	CHEMBL5938	Homo sapiens	IC50	uM	13.37
Not Active	18298081	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4130094		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298082	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4126831		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298083	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4128878		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298084	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(OC)cc1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4130239		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298085	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4127627		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298086	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@@H](NC(C)=O)[C@@H](C)O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4129028		IC50			CHEMBL5938	Homo sapiens	IC50		
Not Active	18298087	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(=O)[C@H](CCC(N)=O)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4126401		IC50			CHEMBL5938	Homo sapiens	IC50		
	18298088	CHEMBL4124061	Inhibition of FITC-GPMQTSpTPKNG-OH binding to Plk2 PBD (unknown origin) after 30 mins by fluorescence polarization assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(Cl)c(Cl)c1)NC(C)=O)[C@@H](C)OP(=O)(O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(N)=O		CHEMBL4127785	=	IC50	nM	715.7	CHEMBL5938	Homo sapiens	IC50	uM	0.7157
	18369899	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCCO)cc3)nc2N1C1CCCC1		CHEMBL4176983	=	IC50	nM	7.86	CHEMBL5938	Homo sapiens	IC50	nM	7.86
	18369900	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCCCO)cc3)nc2N1C1CCCC1		CHEMBL4169129	=	IC50	nM	8.16	CHEMBL5938	Homo sapiens	IC50	nM	8.16
	18369901	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(Nc3ccc(S(N)(=O)=O)cc3)nc2N1c1ccn(C)n1		CHEMBL4161861	=	IC50	nM	120.6	CHEMBL5938	Homo sapiens	IC50	nM	120.6
	18369902	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NC)cc3)nc2N1c1ccn(C)n1		CHEMBL4172511	=	IC50	nM	71.55	CHEMBL5938	Homo sapiens	IC50	nM	71.55
	18369903	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)N(c2ccn(C)n2)C(CC)C(=O)N3C)cc1		CHEMBL4168834	=	IC50	nM	189.6	CHEMBL5938	Homo sapiens	IC50	nM	189.6
	18369904	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)N(c2ccn(C)n2)C(CC)C(=O)N3C)cc1		CHEMBL4176689	=	IC50	nM	190.7	CHEMBL5938	Homo sapiens	IC50	nM	190.7
	18369905	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCC(C)C)cc3)nc2N1c1ccn(C)n1		CHEMBL4165409	=	IC50	nM	311.0	CHEMBL5938	Homo sapiens	IC50	nM	311.0
	18369906	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCCO)cc3)nc2N1c1ccn(C)n1		CHEMBL4173322	=	IC50	nM	478.3	CHEMBL5938	Homo sapiens	IC50	nM	478.3
	18369907	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCCCO)cc3)nc2N1c1ccn(C)n1		CHEMBL4175615	=	IC50	nM	192.0	CHEMBL5938	Homo sapiens	IC50	nM	192.0
	18369908	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4ccccc43)nc2N1C1CCCC1		CHEMBL4164991	=	IC50	nM	354.7	CHEMBL5938	Homo sapiens	IC50	nM	354.7
	18369909	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(F)ccc43)nc2N1C1CCCC1		CHEMBL4172185	=	IC50	nM	969.2	CHEMBL5938	Homo sapiens	IC50	nM	969.2
	18369910	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(C(N)=O)ccc43)nc2N1C1CCCC1		CHEMBL4161572	=	IC50	nM	28.51	CHEMBL5938	Homo sapiens	IC50	nM	28.51
	18369911	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC)ccc43)nc2N1C1CCCC1		CHEMBL4163892	=	IC50	nM	8.6	CHEMBL5938	Homo sapiens	IC50	nM	8.6
	18369912	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c1		CHEMBL4171770	=	IC50	nM	4.88	CHEMBL5938	Homo sapiens	IC50	nM	4.88
	18369913	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)Nc4ccccc4)cc3)nc2N1C1CCCC1		CHEMBL4165706	=	IC50	nM	54.4	CHEMBL5938	Homo sapiens	IC50	nM	54.4
	18369914	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NC4CCCC4)cc3)nc2N1C1CCCC1		CHEMBL4173620	=	IC50	nM	23.87	CHEMBL5938	Homo sapiens	IC50	nM	23.87
	18369915	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NCC(C)C)cc3)nc2N1C1CCCC1		CHEMBL4162262	=	IC50	nM	21.77	CHEMBL5938	Homo sapiens	IC50	nM	21.77
	18369916	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)cc1		CHEMBL4170176	=	IC50	nM	19.85	CHEMBL5938	Homo sapiens	IC50	nM	19.85
	18369917	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCNS(=O)(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)cc1		CHEMBL4177399	=	IC50	nM	17.77	CHEMBL5938	Homo sapiens	IC50	nM	17.77
	18369918	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(=O)(=O)NC)cc3)nc2N1C1CCCC1		CHEMBL4166771	=	IC50	nM	3.4	CHEMBL5938	Homo sapiens	IC50	nM	3.4
	18369919	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(S(N)(=O)=O)cc3)nc2N1C1CCCC1		CHEMBL4168155	=	IC50	nM	10.17	CHEMBL5938	Homo sapiens	IC50	nM	10.17
	18369951	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	957.2	CHEMBL5938	Homo sapiens	IC50	nM	957.2
	18369952	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	13.55	CHEMBL5938	Homo sapiens	IC50	nM	13.55
	18369953	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC5CCCC5)ccc43)nc2N1c1ccn(C)n1		CHEMBL4164082	=	IC50	nM	90.93	CHEMBL5938	Homo sapiens	IC50	nM	90.93
	18369954	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NCC(C)C)ccc43)nc2N1c1ccn(C)n1		CHEMBL4174735	=	IC50	nM	158.8	CHEMBL5938	Homo sapiens	IC50	nM	158.8
	18369955	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(c2ccn(C)n2)C(CC)C(=O)N3C)c1		CHEMBL4160679	=	IC50	nM	159.0	CHEMBL5938	Homo sapiens	IC50	nM	159.0
	18369956	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC(C)C)ccc43)nc2N1c1ccn(C)n1		CHEMBL4171281	=	IC50	nM	124.5	CHEMBL5938	Homo sapiens	IC50	nM	124.5
	18369957	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(c2ccn(C)n2)C(CC)C(=O)N3C)c1		CHEMBL4161027	=	IC50	nM	206.7	CHEMBL5938	Homo sapiens	IC50	nM	206.7
	18369958	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(c2ccn(C)n2)C(CC)C(=O)N3C)c1		CHEMBL4168951	=	IC50	nM	242.5	CHEMBL5938	Homo sapiens	IC50	nM	242.5
	18369959	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC)ccc43)nc2N1c1ccn(C)n1		CHEMBL4164433	=	IC50	nM	217.7	CHEMBL5938	Homo sapiens	IC50	nM	217.7
	18369960	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(C(N)=O)ccc43)nc2N1c1ccn(C)n1		CHEMBL4172312	=	IC50	nM	384.3	CHEMBL5938	Homo sapiens	IC50	nM	384.3
	18369961	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCC1C(=O)N(C)c2cnc(-n3ccc4cc(F)ccc43)nc2N1c1ccn(C)n1		CHEMBL4167865	=	IC50	nM	1500.0	CHEMBL5938	Homo sapiens	IC50	nM	1500.0
	18369962	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC5CCCC5)ccc43)nc2N1C1CCCC1		CHEMBL4175722	=	IC50	nM	7.06	CHEMBL5938	Homo sapiens	IC50	nM	7.06
	18369963	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NCC(C)C)ccc43)nc2N1C1CCCC1		CHEMBL4171224	=	IC50	nM	18.62	CHEMBL5938	Homo sapiens	IC50	nM	18.62
	18369964	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c1		CHEMBL4160611	=	IC50	nM	16.52	CHEMBL5938	Homo sapiens	IC50	nM	16.52
	18369965	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccc4cc(C(=O)NC(C)C)ccc43)nc2N1C1CCCC1		CHEMBL4174667	=	IC50	nM	17.41	CHEMBL5938	Homo sapiens	IC50	nM	17.41
	18369966	CHEMBL4143483	Inhibition human recombinant full length GST-tagged Plk2 expressed in baculovirus expression system after 1 hr by FRET-based Z'-Lyte assay	B	CCCNC(=O)c1ccc2c(ccn2-c2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c1		CHEMBL4164012	=	IC50	nM	11.35	CHEMBL5938	Homo sapiens	IC50	nM	11.35
	18379941	CHEMBL4145842	Inhibition of PLK2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1	Outside typical range	CHEMBL4159506	=	Inhibition	%	-10.2	CHEMBL5938	Homo sapiens	INH	%	-10.2
	18379993	CHEMBL4145894	Inhibition of PLK2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	365.9	CHEMBL5938	Homo sapiens	IC50	nM	365.9
	18440401	CHEMBL4157225	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	96.0	CHEMBL5938	Homo sapiens	Activity	%	96.0
	18484357	CHEMBL4186004	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	90.0	CHEMBL5938	Homo sapiens	Activity	%	90.0
	18484841	CHEMBL4186004	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	74.0	CHEMBL5938	Homo sapiens	Activity	%	74.0
	18507600	CHEMBL4191197	Inhibition of recombinant human Snk (65 to 409 residues) at 1 uM using casein as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-6.0	CHEMBL5938	Homo sapiens	INH	%	-6.0
	18555914	CHEMBL4200429	Inhibition of human PLK2 expressed in mammalian expression system assessed as remaining enzyme activity at 1 uM	B	COc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)[C@H](C)C(=O)N2C		CHEMBL4209902	=	Activity	%	0.3	CHEMBL5938	Homo sapiens	Activity	%	0.3
	18655331	CHEMBL4230904	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	87.0	CHEMBL5938	Homo sapiens	Activity	%	87.0
Not Active	18659172	CHEMBL4231775	Inhibition of PLK2 (unknown origin)	B	CCCCCc1cc2nn(-c3ccccc3)cc2cn1		CHEMBL4249686		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	18752156	CHEMBL4264493	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	18764350	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N[C@H]1Cc2c[n+](cn2CCCCCCCCc2ccccc2)CCCCCNC(=O)[C@H]([C@@H](C)OP(=O)(O)O)NC(=O)[C@H](CO)NC1=O		CHEMBL4287557	=	IC50	nM	3100.0	CHEMBL5938	Homo sapiens	IC50	nM	3100.0
	18764351	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1Cc2c[n+](cn2CCCCCCCCc2ccccc2)CCCCCCNC(=O)[C@H]([C@@H](C)OP(=O)(O)O)NC(=O)[C@H](CO)NC1=O		CHEMBL4278200	=	IC50	nM	110.0	CHEMBL5938	Homo sapiens	IC50	nM	110.0
	18764352	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1Cc2c[n+](cn2CCCCCCCCc2ccccc2)CCCCCNC(=O)[C@H]([C@@H](C)OP(=O)(O)O)NC(=O)[C@H](CO)NC1=O		CHEMBL4281659	=	IC50	nM	150.0	CHEMBL5938	Homo sapiens	IC50	nM	150.0
	18764353	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1Cc2c[n+](cn2CCCCCCCCc2ccccc2)CCCCNC(=O)[C@H]([C@@H](C)OP(=O)(O)O)NC(=O)[C@H](CO)NC1=O		CHEMBL4292295	=	IC50	nM	610.0	CHEMBL5938	Homo sapiens	IC50	nM	610.0
Not Determined	18764354	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL4285090		IC50			CHEMBL5938	Homo sapiens	IC50		
	18764355	CHEMBL4267035	Inhibition of 5CF-GPMQTSpTPKNG-NH2 binding to Plk2 C-terminal polo-box domain (unknown origin) preincubated for 30 mins followed by probe addition measured after 30 mins by fluorescence polarization assay	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cncn1CCCCCCCCc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N)=O)[C@@H](C)OP(=O)(O)O		CHEMBL2207845	=	IC50	nM	570.0	CHEMBL5938	Homo sapiens	IC50	nM	570.0
	18858156	CHEMBL4308002	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	97.0	CHEMBL5938	Homo sapiens	Activity	%	97.0
	18892722	CHEMBL4314526	Inhibition of human Snk (65 to 409 residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	105.5	CHEMBL5938	Homo sapiens	Activity	%	105.5
	18938253	CHEMBL4327853	Inhibition of human PLK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	96.63	CHEMBL5938	Homo sapiens	Activity	%	96.63
	18938254	CHEMBL4327853	Inhibition of human PLK2 assessed as residual activity at 1 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.34	CHEMBL5938	Homo sapiens	Activity	%	96.34
	18938698	CHEMBL4328217	Inhibition of human PLK2 assessed as residual activity at 100 uM using casein as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5938	Homo sapiens	Activity	%	65.0
	18939082	CHEMBL4328581	Inhibition of human PLK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	471.0	CHEMBL5938	Homo sapiens	IC50	10'-7M	4.71
	18958604	CHEMBL4333587	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	67.0	CHEMBL5938	Homo sapiens	Activity	%	67.0
	18964700	CHEMBL4335291	Inhibition of human Snk (65 to 409 residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL5938	Homo sapiens	Activity	%	92.0
	18964701	CHEMBL4335291	Inhibition of human Snk (65 to 409 residues) assessed as residual activity at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	91.0	CHEMBL5938	Homo sapiens	Activity	%	91.0
	18972106	CHEMBL4337116	Inhibition of recombinant human SNK (65 to 409 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	90.0	CHEMBL5938	Homo sapiens	Activity	%	90.0
Not Active	19040164	CHEMBL4352065	Inhibition of human Snk (65 to 409 residues) using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Active	19041259	CHEMBL4352520	Inhibition of human PLK2 at 10 uM using casein as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	19059781	CHEMBL4358082	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	19090345	CHEMBL4365919	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	33.0	CHEMBL5938	Homo sapiens	Activity	%	33.0
	19092092	CHEMBL4366566	Inhibition of human PLK2 at 100 nM using casein as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	4.64	CHEMBL5938	Homo sapiens	INH	%	4.64
	19133360	CHEMBL4375349	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system measured after 1 hr by kinomescan method	B	O=C(Nc1ccc2cc(C(=O)Nc3nccs3)ccc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL4445812	=	Kd	nM	272.0	CHEMBL5938	Homo sapiens	Kd	nM	272.0
	19144891	CHEMBL4377907	Inhibition of human Snk (65 to 409 residues) at 1 uM using casein as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	4.0	CHEMBL5938	Homo sapiens	INH	%	4.0
	19148044	CHEMBL4379440	Inhibition of recombinant human SNK (65 to 409 residues) using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	19159609	CHEMBL4382713	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	87.0	CHEMBL5938	Homo sapiens	Activity	%	87.0
	19181123	CHEMBL4387334	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	0.5	CHEMBL5938	Homo sapiens	INH	%	0.5
	19181348	CHEMBL4387334	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-16 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	3.0	CHEMBL5938	Homo sapiens	INH	%	3.0
	19191398	CHEMBL4389432	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	78.0	CHEMBL5938	Homo sapiens	INH	%	78.0
	19192095	CHEMBL4389909	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	87.0	CHEMBL5938	Homo sapiens	INH	%	87.0
	19200351	CHEMBL4391535	Binding affinity to wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	80.0	CHEMBL5938	Homo sapiens	Activity	%	80.0
	19266586	CHEMBL4405536	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5938	Homo sapiens	INH	%	50.0
	19276133	CHEMBL4408136	Inhibition of recombinant human SNK (65 to 409 residues) at 1 uM using casein as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	47.0	CHEMBL5938	Homo sapiens	INH	%	47.0
	19283985	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL4592698	=	IC50	nM	3.98	CHEMBL5938	Homo sapiens	IC50	nM	3.98
	19283986	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(CCO)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL4468970	=	IC50	nM	3474.0	CHEMBL5938	Homo sapiens	IC50	nM	3474.0
	19283987	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(COC)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL4524869	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	19283988	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)Nc2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL4450564	=	IC50	nM	75.77	CHEMBL5938	Homo sapiens	IC50	nM	75.77
	19283989	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3O)nc2N1C1CCCC1		CHEMBL4548940	=	IC50	nM	7.98	CHEMBL5938	Homo sapiens	IC50	nM	7.98
	19283990	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3C)nc2N1C1CCCC1		CHEMBL4454222	=	IC50	nM	4.72	CHEMBL5938	Homo sapiens	IC50	nM	4.72
	19283991	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OCc3ccccc3)nc2N1C1CCCC1		CHEMBL4454586	=	IC50	nM	1796.9	CHEMBL5938	Homo sapiens	IC50	nM	1796.9
	19283992	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OCCOC)nc2N1C1CCCC1		CHEMBL4587599	=	IC50	nM	898.4	CHEMBL5938	Homo sapiens	IC50	nM	898.4
	19283993	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3CCO)nc2N1C1CCCC1		CHEMBL4436925	=	IC50	nM	36.04	CHEMBL5938	Homo sapiens	IC50	nM	36.04
	19283994	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4531932	=	IC50	nM	152.0	CHEMBL5938	Homo sapiens	IC50	nM	152.0
	19283995	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4450624	=	IC50	nM	338.7	CHEMBL5938	Homo sapiens	IC50	nM	338.7
	19283996	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCOCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4519294	=	IC50	nM	230.9	CHEMBL5938	Homo sapiens	IC50	nM	230.9
	19283997	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C(C)C)CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4515187	=	IC50	nM	743.9	CHEMBL5938	Homo sapiens	IC50	nM	743.9
	19283998	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(C)=O)cc3OCCO)nc2N1C1CCCC1		CHEMBL4447251	=	IC50	nM	131.7	CHEMBL5938	Homo sapiens	IC50	nM	131.7
	19283999	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(N)=O)cc3OCCO)nc2N1C1CCCC1		CHEMBL4461041	=	IC50	nM	290.5	CHEMBL5938	Homo sapiens	IC50	nM	290.5
	19284000	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC)cc3OCCO)nc2N1C1CCCC1		CHEMBL4566834	=	IC50	nM	195.9	CHEMBL5938	Homo sapiens	IC50	nM	195.9
	19284001	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CCNC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OCCO)c1		CHEMBL4545446	=	IC50	nM	314.2	CHEMBL5938	Homo sapiens	IC50	nM	314.2
	19284002	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC(C)C)cc3OCCO)nc2N1C1CCCC1		CHEMBL4448563	=	IC50	nM	85.11	CHEMBL5938	Homo sapiens	IC50	nM	85.11
	19284003	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4574255	=	IC50	nM	640.8	CHEMBL5938	Homo sapiens	IC50	nM	640.8
	19284004	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CCCNC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OCCO)c1		CHEMBL4574072	=	IC50	nM	626.2	CHEMBL5938	Homo sapiens	IC50	nM	626.2
	19284005	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CCCCNC(=O)c1ccc(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)c(OCCO)c1		CHEMBL4453584	=	IC50	nM	498.0	CHEMBL5938	Homo sapiens	IC50	nM	498.0
	19284006	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCN4CCN(C)CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4576641	=	IC50	nM	873.6	CHEMBL5938	Homo sapiens	IC50	nM	873.6
	19284007	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCN4CCOCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4529398	=	IC50	nM	385.3	CHEMBL5938	Homo sapiens	IC50	nM	385.3
	19284008	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NCCN(C)C)cc3OCCO)nc2N1C1CCCC1		CHEMBL4449123	=	IC50	nM	265.1	CHEMBL5938	Homo sapiens	IC50	nM	265.1
	19284009	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCC4)cc3OCCO)nc2N1C(C)C		CHEMBL4473297	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	19284010	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OCCO)nc2N1C(C)C		CHEMBL4449490	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	19284011	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCOCC4)cc3OCCO)nc2N1C(C)C		CHEMBL4469319	>	IC50	nM	10000.0	CHEMBL5938	Homo sapiens	IC50	uM	10.0
	19284012	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCN(C)CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4459892	=	IC50	nM	122.2	CHEMBL5938	Homo sapiens	IC50	nM	122.2
	19284013	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCOCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4441121	=	IC50	nM	61.17	CHEMBL5938	Homo sapiens	IC50	nM	61.17
	19284014	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC)cc3OCCO)nc2N1C1CCCC1		CHEMBL4456400	=	IC50	nM	107.2	CHEMBL5938	Homo sapiens	IC50	nM	107.2
	19284015	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CCNC(=O)c1cc(OCCO)c(Nc2ncc3c(n2)N(C2CCCC2)[C@H](CC)C(=O)N3C)cc1F		CHEMBL4570557	=	IC50	nM	107.0	CHEMBL5938	Homo sapiens	IC50	nM	107.0
	19284016	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC(C)C)cc3OCCO)nc2N1C1CCCC1		CHEMBL4457656	=	IC50	nM	33.83	CHEMBL5938	Homo sapiens	IC50	nM	33.83
	19284017	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4458460	=	IC50	nM	30.51	CHEMBL5938	Homo sapiens	IC50	nM	30.51
	19284018	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NCCN4CCN(C)CC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4447495	=	IC50	nM	167.3	CHEMBL5938	Homo sapiens	IC50	nM	167.3
	19284019	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NCCN4CCOCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4573833	=	IC50	nM	397.3	CHEMBL5938	Homo sapiens	IC50	nM	397.3
	19284020	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NCCN(C)C)cc3OCCO)nc2N1C1CCCC1		CHEMBL4515755	=	IC50	nM	3180.0	CHEMBL5938	Homo sapiens	IC50	nM	3180.0
	19284021	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCN(C)CC4)cc3OCCO)nc2N1C(C)C		CHEMBL4442768	=	IC50	nM	718.3	CHEMBL5938	Homo sapiens	IC50	nM	718.3
	19284022	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCOCC4)cc3OCCO)nc2N1C(C)C		CHEMBL4541823	=	IC50	nM	868.7	CHEMBL5938	Homo sapiens	IC50	nM	868.7
	19284023	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	957.2	CHEMBL5938	Homo sapiens	IC50	nM	957.2
	19284024	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	13.55	CHEMBL5938	Homo sapiens	IC50	nM	13.55
	19284025	CHEMBL4409681	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using ser/thr 16 as substrate incubated for 1 hr by Z'-LYTE assay	B	CCC1C(=O)N(C)c2cnc(Nc3cc(F)c(C(=O)NC4CCCC4)cc3OCCO)nc2N1C1CCCC1		CHEMBL4465062	=	IC50	nM	643.0	CHEMBL5938	Homo sapiens	IC50	nM	643.0
	19430012	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	Cc1ccc(/C(=N/CS(=O)(=O)c2ccccc2)NC(=S)Nc2ccc([N+](=O)[O-])cc2)cc1	Outside typical range	CHEMBL4553039	=	Kd	nM	159000.0	CHEMBL5938	Homo sapiens	Kd	uM	159.0
	19430013	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	Cc1ccccc1OCC(=O)N/N=C/c1ccc2c(c1)OCCO2	Outside typical range	CHEMBL1965126	=	Kd	nM	197000.0	CHEMBL5938	Homo sapiens	Kd	uM	197.0
Not Determined	19430014	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	O=C(N/N=C/c1ccc(Br)cc1)c1n[nH]c2c1CCCC2		CHEMBL4587212		Kd			CHEMBL5938	Homo sapiens	Kd		
	19430015	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	O=C(CCn1c2ccccc2c2ccccc21)N/N=C/c1cc(Cl)cc(Cl)c1	Outside typical range	CHEMBL4460805	=	Kd	nM	210000.0	CHEMBL5938	Homo sapiens	Kd	uM	210.0
Not Determined	19430016	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CCn1c2ccccc2c2cc(/C=N/NC(=O)c3cccc(Cl)c3)ccc21		CHEMBL4451672		Kd			CHEMBL5938	Homo sapiens	Kd		
Not Determined	19430017	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CCc1ccc(/C=N/NC(=O)C2=C(Cl)c3ccc(Cl)cc3C2)s1		CHEMBL4439895		Kd			CHEMBL5938	Homo sapiens	Kd		
Not Determined	19430018	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CCn1c2ccccc2c2cc(/C=N/NC(=O)c3ccccc3[N+](=O)[O-])ccc21		CHEMBL4560457		Kd			CHEMBL5938	Homo sapiens	Kd		
Not Determined	19430019	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CCN(CC)c1ccc(NC(=O)/C=C/c2cccc3ccccc23)cc1		CHEMBL4553008		Kd			CHEMBL5938	Homo sapiens	Kd		
Not Determined	19430020	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	Cc1ccc2nc(C)cc(SCC(=O)N/N=C/c3ccc(Cl)cc3)c2c1		CHEMBL4468878		Kd			CHEMBL5938	Homo sapiens	Kd		
Not Determined	19430021	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CCCc1oc2ccc(NS(=O)(=O)c3cccs3)cc2c1C(=O)OCC		CHEMBL4441252		Kd			CHEMBL5938	Homo sapiens	Kd		
	19430022	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CC1=CC(=O)C(C(C)C)=C/C1=N/OC(=O)c1ccccc1C		CHEMBL3944542	=	Kd	nM	87300.0	CHEMBL5938	Homo sapiens	Kd	uM	87.3
Not Determined	19430023	CHEMBL4428741	Binding affinity to GST-tagged PLK2 PBD (355 to 685 residues) (unknown origin) by NT-647 dye-based microscale thermophoresis analysis	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)OP(=O)(O)O		CHEMBL4447981		Kd			CHEMBL5938	Homo sapiens	Kd		
	20600634	CHEMBL4603586	Inhibition of recombinant full length human GST-tagged PLK2 expressed in baculovirus expression system using serine/threonine-16 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5938	Homo sapiens	IC50	uM	100.0
	22392144	CHEMBL4667239	Inhibition of recombinant human GST-tagged full length PLK2 expressed in baculovirus expression system using Ser/Thr 16 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-1.0	CHEMBL5938	Homo sapiens	INH	%	-1.0
	22423293	CHEMBL4674222	Inhibition of human PLK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	108.32	CHEMBL5938	Homo sapiens	Activity	%	108.32
	22423294	CHEMBL4674222	Inhibition of human PLK2 using casein as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	90.22	CHEMBL5938	Homo sapiens	Activity	%	90.22
Not Active	22434776	CHEMBL4677357	Inhibition of FITC-Ahx-DPPLHSpTAI-NH2 binding to Plk2 PBD (unknown origin) expressed in bacterial expression system measured after 30 mins by fluorescence polarization assay	A	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)O		CHEMBL2396736		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	22434777	CHEMBL4677357	Inhibition of FITC-Ahx-DPPLHSpTAI-NH2 binding to Plk2 PBD (unknown origin) expressed in bacterial expression system measured after 30 mins by fluorescence polarization assay	A	O=c1c2cc(F)ccc2n2c(=S)[nH]nc2n1CC1CC1		CHEMBL4786053		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
Not Active	22434778	CHEMBL4677357	Inhibition of FITC-Ahx-DPPLHSpTAI-NH2 binding to Plk2 PBD (unknown origin) expressed in bacterial expression system measured after 30 mins by fluorescence polarization assay	A	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)O)[C@@H](C)OP(=O)(O)O		CHEMBL2323729		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	22843591	CHEMBL4720577	Inhibition of human PLK2 using casein as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	328.0	CHEMBL5938	Homo sapiens	IC50	10^-7M	3.28
	22843935	CHEMBL4720921	Inhibition of human PLK2 assessed as residual activity using casein as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	95.41	CHEMBL5938	Homo sapiens	Activity	%	95.41
	22844845	CHEMBL4721520	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	89.41	CHEMBL5938	Homo sapiens	Activity	%	89.41
Not Active	22889553	CHEMBL4729072	Inhibition of wild-type human partial length PLK2 (H58 to F354 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL5938	Homo sapiens	INH		
	22953003	CHEMBL4766940	Inhibition of recombinant human SNK (65 to 409 residues) assessed as residual activity at 10 uM using casein as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	84.0	CHEMBL5938	Homo sapiens	Activity	%	84.0
	23122766	CHEMBL4805117	Inhibition of human PLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	80.0	CHEMBL5938	Homo sapiens	Activity	%	80.0
	23123461	CHEMBL4805705	Inhibition of human PLK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	55.0	CHEMBL5938	Homo sapiens	Activity	%	55.0
	23123916	CHEMBL4806160	Inhibition of DNA-tagged human PLK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	94.0	CHEMBL5938	Homo sapiens	Activity	%	94.0
	23125012	CHEMBL4806722	Inhibition of human PLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5938	Homo sapiens	Activity	%	100.0
	23125013	CHEMBL4806722	Inhibition of human PLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL5938	Homo sapiens	Activity	%	86.0
	23128593	CHEMBL4808006	Inhibition of SNK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL5938	Homo sapiens	Activity	%	75.0
	23128594	CHEMBL4808006	Inhibition of SNK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL5938	Homo sapiens	Activity	%	75.0
	23128595	CHEMBL4808006	Inhibition of SNK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL5938	Homo sapiens	Activity	%	75.0
	23128930	CHEMBL4808106	Inhibition of PLK2 (unknown origin) at 0.5 uM relative to control	B	CSc1nc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3Br)cc2)c(-c2ccc(F)cc2)o1		CHEMBL4875968	=	Inhibition	%	19.0	CHEMBL5938	Homo sapiens	INH	%	19.0
	23312263	CHEMBL4844319	Inhibition of PLK2 (unknown origin) at 1 uM relative to control	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)[C@](C)(O)CC2		CHEMBL4871803	>	Inhibition	%	90.0	CHEMBL5938	Homo sapiens	INH	%	90.0
	23312264	CHEMBL4844319	Inhibition of PLK2 (unknown origin) at 1 uM relative to control	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)C(O)(CC)CC2		CHEMBL4871593	>=	Inhibition	%	90.0	CHEMBL5938	Homo sapiens	INH	%	90.0
	23312280	CHEMBL4844333	Inhibition of PLK2 (unknown origin)	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1ccc2c(n1)C(O)(CC)CC2		CHEMBL4871593	=	IC50	nM	40.0	CHEMBL5938	Homo sapiens	IC50	nM	40.0
Not Active	23317602	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	78.0	CHEMBL5938	Homo sapiens	% Control	%	78.0
Not Active	23318070	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23318736	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	94.0	CHEMBL5938	Homo sapiens	% Control	%	94.0
Not Active	23319220	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	86.0	CHEMBL5938	Homo sapiens	% Control	%	86.0
Not Active	23319857	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	67.1	CHEMBL5938	Homo sapiens	% Control	%	67.1
Not Active	23320332	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	98.4	CHEMBL5938	Homo sapiens	% Control	%	98.4
Not Active	23321010	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23321478	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	71.0	CHEMBL5938	Homo sapiens	% Control	%	71.0
Not Active	23322108	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	79.0	CHEMBL5938	Homo sapiens	% Control	%	79.0
Not Active	23322576	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	86.0	CHEMBL5938	Homo sapiens	% Control	%	86.0
Not Active	23323265	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	81.0	CHEMBL5938	Homo sapiens	% Control	%	81.0
Not Active	23323733	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23324138	CHEMBL4880756	Snk (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	3.0	CHEMBL5938	Homo sapiens	% inhibition	%	3.0
Not Active	23324587	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23325222	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23325690	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	92.0	CHEMBL5938	Homo sapiens	% Control	%	92.0
Not Active	23326337	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	73.0	CHEMBL5938	Homo sapiens	% Control	%	73.0
Not Active	23326805	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	84.0	CHEMBL5938	Homo sapiens	% Control	%	84.0
Not Active	23327505	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	76.0	CHEMBL5938	Homo sapiens	% Control	%	76.0
Not Active	23327973	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	74.0	CHEMBL5938	Homo sapiens	% Control	%	74.0
Not Active	23328560	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	78.0	CHEMBL5938	Homo sapiens	% Control	%	78.0
Not Active	23329028	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23329531	CHEMBL4881238	Snk(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	119.0	CHEMBL5938	Homo sapiens	% residual kinase activity	%	119.0
Not Active	23329974	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	93.0	CHEMBL5938	Homo sapiens	% Control	%	93.0
Not Active	23330442	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	74.0	CHEMBL5938	Homo sapiens	% Control	%	74.0
Not Active	23331198	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23331666	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23332253	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	83.3	CHEMBL5938	Homo sapiens	% Control	%	83.3
Not Active	23332719	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23333437	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	97.8	CHEMBL5938	Homo sapiens	% Control	%	97.8
Not Active	23334076	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	82.0	CHEMBL5938	Homo sapiens	% Control	%	82.0
Not Active	23334544	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	83.0	CHEMBL5938	Homo sapiens	% Control	%	83.0
Not Active	23335523	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	59.0	CHEMBL5938	Homo sapiens	% Control	%	59.0
Not Active	23335991	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	83.0	CHEMBL5938	Homo sapiens	% Control	%	83.0
Not Active	23336618	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	89.0	CHEMBL5938	Homo sapiens	% Control	%	89.0
Not Active	23337086	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	82.0	CHEMBL5938	Homo sapiens	% Control	%	82.0
Not Active	23337731	CHEMBL4882102	PLK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	90.0	CHEMBL5938	Homo sapiens	% Ctrl	%	90.0
Not Active	23338167	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	56.0	CHEMBL5938	Homo sapiens	% Control	%	56.0
Not Active	23338635	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	93.0	CHEMBL5938	Homo sapiens	% Control	%	93.0
Not Active	23339247	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	91.0	CHEMBL5938	Homo sapiens	% Control	%	91.0
Not Active	23339715	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23340352	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	70.0	CHEMBL5938	Homo sapiens	% Control	%	70.0
Not Active	23340820	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23341477	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	93.0	CHEMBL5938	Homo sapiens	% Control	%	93.0
Not Active	23341945	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	80.0	CHEMBL5938	Homo sapiens	% Control	%	80.0
Not Active	23342561	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	96.0	CHEMBL5938	Homo sapiens	% Control	%	96.0
Not Active	23343029	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23343659	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	80.0	CHEMBL5938	Homo sapiens	% Control	%	80.0
Not Active	23344127	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23344765	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	88.0	CHEMBL5938	Homo sapiens	% Control	%	88.0
Not Active	23345338	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	69.0	CHEMBL5938	Homo sapiens	% Control	%	69.0
Not Active	23345806	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	93.0	CHEMBL5938	Homo sapiens	% Control	%	93.0
Not Active	23346383	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23346851	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23347453	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	95.1	CHEMBL5938	Homo sapiens	% Control	%	95.1
Not Active	23347943	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23348522	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23348990	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	96.0	CHEMBL5938	Homo sapiens	% Control	%	96.0
Not Active	23349577	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23350195	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23350663	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23351268	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	92.0	CHEMBL5938	Homo sapiens	% Control	%	92.0
Not Active	23351736	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	90.0	CHEMBL5938	Homo sapiens	% Control	%	90.0
Not Active	23352184	CHEMBL4882873	PLK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	12.72	CHEMBL5938	Homo sapiens	% Inhibition	%	12.7193
Not Active	23352760	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	76.0	CHEMBL5938	Homo sapiens	% Control	%	76.0
Not Active	23353228	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	68.0	CHEMBL5938	Homo sapiens	% Control	%	68.0
Not Active	23354110	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23354578	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23355310	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23355778	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23356414	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23356882	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	94.0	CHEMBL5938	Homo sapiens	% Control	%	94.0
Not Active	23357491	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23358138	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23358606	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	60.0	CHEMBL5938	Homo sapiens	% Control	%	60.0
Not Active	23359192	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	56.7	CHEMBL5938	Homo sapiens	% Control	%	56.7
Not Active	23359790	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	92.0	CHEMBL5938	Homo sapiens	% Control	%	92.0
Not Active	23360258	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	97.0	CHEMBL5938	Homo sapiens	% Control	%	97.0
Not Active	23360843	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	91.0	CHEMBL5938	Homo sapiens	% Control	%	91.0
Not Active	23361311	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23361884	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	76.0	CHEMBL5938	Homo sapiens	% Control	%	76.0
Not Active	23362420	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23362888	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	82.0	CHEMBL5938	Homo sapiens	% Control	%	82.0
Not Active	23364530	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23364998	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23365737	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	94.0	CHEMBL5938	Homo sapiens	% Control	%	94.0
Not Active	23366280	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	81.0	CHEMBL5938	Homo sapiens	% Control	%	81.0
Not Active	23366870	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23367338	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23367748	CHEMBL4884101	SNK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	103.0	CHEMBL5938	Homo sapiens	% Residual activity with Skepinone-L	%	103.0
Not Active	23368216	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23368684	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23369283	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23369751	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23370247	CHEMBL4884486	Snk(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL5938	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370719	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	97.0	CHEMBL5938	Homo sapiens	% Control	%	97.0
Not Active	23371187	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	74.0	CHEMBL5938	Homo sapiens	% Control	%	74.0
Not Active	23371996	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23372464	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	99.0	CHEMBL5938	Homo sapiens	% Control	%	99.0
Not Active	23375079	CHEMBL4886067	PLK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-3.5	CHEMBL5938	Homo sapiens	% Inhibition	%	-3.5
Not Active	23375340	CHEMBL4886322	polo-like kinase 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-7.0	CHEMBL5938	Homo sapiens	% inhibition	%	-7.0
Not Active	23375891	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	92.0	CHEMBL5938	Homo sapiens	% Control	%	92.0
Not Active	23376359	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	86.0	CHEMBL5938	Homo sapiens	% Control	%	86.0
Not Active	23376936	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	95.0	CHEMBL5938	Homo sapiens	% Control	%	95.0
Not Active	23377404	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	97.0	CHEMBL5938	Homo sapiens	% Control	%	97.0
Not Active	23378264	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	91.0	CHEMBL5938	Homo sapiens	% Control	%	91.0
Not Active	23378732	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	92.0	CHEMBL5938	Homo sapiens	% Control	%	92.0
Not Active	23379899	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	80.0	CHEMBL5938	Homo sapiens	% Control	%	80.0
Not Active	23380367	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23381061	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23381709	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	75.0	CHEMBL5938	Homo sapiens	% Control	%	75.0
Not Active	23382177	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	98.0	CHEMBL5938	Homo sapiens	% Control	%	98.0
Not Active	23382801	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	77.0	CHEMBL5938	Homo sapiens	% Control	%	77.0
Active	23383269	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	0.5	CHEMBL5938	Homo sapiens	% Control	%	0.5
Not Active	23383942	CHEMBL4887551	PLK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL5938	Homo sapiens	% Ctrl	%	96.0
Not Active	23384468	CHEMBL4888063	Snk(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	7.48	CHEMBL5938	Homo sapiens	% inhibition	%	7.48
Not Active	23385184	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
Not Active	23385651	CHEMBL4879908	KinomeScan assay: inhibition of PLK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5938	Homo sapiens	% Control	%	100.0
